Filing Flows

Filing Flows › Usana Health Sciences (USNA) › Next earnings date

Usana Health Sciences (USNA) earnings: missed the estimate

Usana Health Sciences (USNA) reported on Nov 3, 2026 and missed the EPS estimate: −$0.11 against $0.11 (-200.0%). It beat the EPS estimate in 40% of the quarters on record.

Last result−200.0% vs estimate
Beat rate40%

The last report

Usana Health Sciences reported revenue of $223M for the second quarter 2026 (-5% Y/Y), net loss $28.0M. How it makes money → · Every quarter →

Usana Health Sciences: EPS against the estimate, last 5 reportsUsana Health Sciences: EPS against the estimate, last 5 reportsEstimateReported−$0.15−$0.15Oct 25$0.41$0.60Feb 26$0.44$0.61May 26$0.43−$0.07Aug 26$0.11−$0.11Nov 26
Latest (Nov 26): Estimate $0.11, Reported −$0.11.
USNA: the stock's move on each reportUSNA: the stock's move on each reportAug 4, 2026-34.4%May 5, 2026+7.8%Feb 17, 2026-9.1%Oct 22, 2025-1.9%

Usana Health Sciences' latest quarter

Usana Health Sciences, Q2 2026: revenue $223M (-5% year over year), operating margin -9.0%, net loss $28.0M, operating cash flow $23.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Usana Health Sciences beat earnings?

Usana Health Sciences (USNA) reported on Nov 3, 2026 and missed the EPS estimate: −$0.11 against $0.11 (-200.0%).

When does USNA report earnings?

The next date is not set yet.

Does Usana Health Sciences usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.